Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Paul J van Diest
Affiliation
University Medical Center Utrecht
ORCID
Career Start Year
1989
Papers
858
H Index
91
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37854018
Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1-NDRG1 deregulation.
Mol Oncol
2024
38017325
MET-receptor targeted fluorescent imaging and spectroscopy to detect multifocal papillary thyroid cancer.
Eur J Nucl Med Mol Imaging
2024
36378325
Dimorphic cells: a common feature throughout the low nuclear grade breast neoplasia spectrum.
Virchows Arch
2023
37491536
A comprehensive multi-domain dataset for mitotic figure detection.
Sci Data
2023
37900554
A Second Ductoscopy Procedure in Patients with Recurrent and Persistent Pathological Nipple Discharge.
Breast Care (Basel)
2023
37608772
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
J Pathol
2023
37608771
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
J Pathol
2023
37925965
External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer.
Eur J Cancer
2023
35835545
Interlaboratory Gleason grading variation affects treatment: a Dutch historic cohort study in 30 509 patients with prostate cancer.
J Clin Pathol
2023
35716369
Clinical significance and molecular annotation of cellular morphometric subtypes in lower-grade gliomas discovered by machine learning.
Neuro Oncol
2023
37459137
Role of duct excision surgery in the treatment of pathological nipple discharge and detection of breast carcinoma: systematic review.
BJS Open
2023
37286323
CONFIDENT-trial protocol: a pragmatic template for clinical implementation of artificial intelligence assistance in pathology.
BMJ Open
2023
37178160
Breast carcinoma detection in ex vivo fresh human breast surgical specimens using a fast slide-free confocal microscopy scanner: HIBISCUSS project.
BJS Open
2023
37406727
R-spondin-3 promotes proliferation and invasion of breast cancer cells independently of Wnt signaling.
Cancer Lett
2023
37273455
Deep learning supported mitoses counting on whole slide images: A pilot study for validating breast cancer grading in the clinical workflow.
J Pathol Inform
2023
37333164
RNA Helicase DDX3 Regulates RAD51 Localization and DNA Damage Repair in Ewing Sarcoma.
bioRxiv
2023
37361508
Time Trends in Histopathological Findings in Mammaplasty Specimens in a Dutch Academic Pathology Laboratory.
Plast Reconstr Surg Glob Open
2023
37330436
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Virchows Arch
2023
36996627
CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma.
Eur J Cancer
2023
36693714
Papillomatous breast lesions with atypical columnar cell features.
J Clin Pathol
2023
36692113
A whole-slide imaging based workflow reduces the reading time of pathologists.
Pathol Int
2023
36843274
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma.
Int J Cancer
2023
36509217
Melanomas in children and adolescents: Clinicopathologic features and survival outcomes.
J Am Acad Dermatol
2023
36762595
Development and validation of risk calculators for people with "thin" melanomas on their skin to predict the likelihood that their cancer will return: a plain language summary of publication.
Future Oncol
2023
36928988
Deep Learning-Based Segmentation of Locally Advanced Breast Cancer on MRI in Relation to Residual Cancer Burden: A Multi-Institutional Cohort Study.
J Magn Reson Imaging
2023
36331594
NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target.
Acta Neuropathol
2023
36328436
Use of the ISUP e-learning module improves interrater reliability in prostate cancer grading.
J Clin Pathol
2023
34196797
Grading of invasive breast carcinoma: the way forward.
Virchows Arch
2022
35587322
Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature.
Breast Cancer Res Treat
2022
35353548
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy.
J Clin Oncol
2022
35610485
Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer.
Oncogene
2022
35437308
Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer.
Oncogene
2022
35792986
Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer.
Cell Oncol (Dordr)
2022
35761221
Patient-centered research: how do women tolerate nipple fluid aspiration as a potential screening tool for breast cancer?
BMC Cancer
2022
35389070
Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissection.
Eur J Nucl Med Mol Imaging
2022
36497229
The microRNA Lifecycle in Health and Cancer.
Cancers (Basel)
2022
36069889
Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer.
JAMA Surg
2022
36068311
Deep learning-based breast cancer grading and survival analysis on whole-slide histopathology images.
Sci Rep
2022
36096039
Imaging to predict checkpoint inhibitor outcomes in cancer. A systematic review.
Eur J Cancer
2022
36127090
Improving prediction of response to neoadjuvant treatment in patients with breast cancer by combining liquid biopsies with multiparametric MRI: protocol of the LIMA study - a multicentre prospective observational cohort study.
BMJ Open
2022
35954468
Elevated miR-29c-5p Expression in Nipple Aspirate Fluid Is Associated with Extremely High Mammographic Breast Density.
Cancers (Basel)
2022
35922548
Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer.
Mod Pathol
2022
36123365
MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes: a systematic review and meta-analysis.
NPJ Breast Cancer
2022
36118293
Feasibility of Narrow-Band Imaging, Intraductal Biopsy, and Laser Ablation During Mammary Ductoscopy: Protocol for an Interventional Study.
Int J Surg Protoc
2022
33858936
Blunt duct adenosis: a separate entity from columnar cell lesions?
J Clin Pathol
2022
35256245
Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomes.
Eur J Cancer
2022
34889530
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma.
J Pathol Clin Res
2022
35219527
Value of routine cytokeratin immunohistochemistry in detecting low volume disease in cervical cancer.
Gynecol Oncol
2022
35123772
Signal transduction pathway activity in high-grade serous carcinoma, its precursors and Fallopian tube epithelium.
Gynecol Oncol
2022
35039951
Prognosis of pregnancy-associated breast cancer: inferior outcome in patients diagnosed during second and third gestational trimesters and lactation.
Breast Cancer Res Treat
2022
1 - 50 of 858
Column Actions
Search
Recommended Authors
Myriam Kossai
INSERM, Universite Clermont Auvergne
Career Start Year
2008
Number of shared co-authors
3
Leonard Da Silva
Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.
Career Start Year
2007
Number of shared co-authors
5
Samuel Leung
University of British Columbia
Career Start Year
2007
Number of shared co-authors
9
Pamela J Provan
Westmead Institute for Medical Research, Westmead Hospital, The University of Sydney
Career Start Year
2006
Number of shared co-authors
0
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Career Start Year
2003
Number of shared co-authors
10
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year
2002
Number of shared co-authors
2
Danh Tran-Thanh
Centre Hospitalier de l'Universite de Montreal
Career Start Year
2002
Number of shared co-authors
0
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year
2002
Number of shared co-authors
9
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year
2002
Number of shared co-authors
11
Rita A Sakr
Universite Libre de Bruxelles
Career Start Year
2000
Number of shared co-authors
9
Lavinia P Middleton
The University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
16
Susan J Done
University Health Network
Career Start Year
1994
Number of shared co-authors
1
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year
1993
Number of shared co-authors
10
Paul N Span
Radboud University Medical Center
Career Start Year
1993
Number of shared co-authors
19
Maria Aparecida Azevedo Koike Folgueira
Center for Translational Oncology, Cancer Institute of the State of Sao Paulo - ICESP
Career Start Year
1993
Number of shared co-authors
0
Wey L Leong
University Health Network
Career Start Year
1992
Number of shared co-authors
1
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year
1991
Number of shared co-authors
20
Christos Markopoulos
National and Kapodistrian University of Athens
Career Start Year
1987
Number of shared co-authors
5
Elizabeth Mallon
Queen Elizabeth University Hospital
Career Start Year
1986
Number of shared co-authors
4
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year
1986
Number of shared co-authors
3
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year
1986
Number of shared co-authors
0
Ossama Tawfik
University of Kansas
Career Start Year
1985
Number of shared co-authors
4
Craig D Shriver
Walter Reed National Military Medical Center
Career Start Year
1985
Number of shared co-authors
4
Rex C Bentley
Duke School of Medicine
Career Start Year
1984
Number of shared co-authors
1
David R McCready
University of Toronto, University Health Network
Career Start Year
1984
Number of shared co-authors
3
Laura J Van't Veer
University of California San Francisco
Career Start Year
1984
Number of shared co-authors
35
Jos?? Palacios
Universidad de Alcala
Career Start Year
1983
Number of shared co-authors
13
Jahn M Nesland
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year
1980
Number of shared co-authors
5
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year
1979
Number of shared co-authors
4
Jeffrey S Ross
Foundation Medicine
Career Start Year
1974
Number of shared co-authors
8
row(s) 1 - 30 of 30
Collaborators
Carolien H M van Deurzen
Erasmus MC Cancer Institute
Co-authored papers
34
Gerrit A Meijer
The Netherlands Cancer Institute
Co-authored papers
31
Marc Vooijs
Maastricht University Medical Centre+
Co-authored papers
23
Peter Bult
Radboud University Medical Center
Co-authored papers
20
Nikolas Stathonikos
University Medical Center Utrecht
Co-authored papers
17
Mitko Veta
Eindhoven University of Technology
Co-authored papers
16
Emile E Voest
The Netherlands Cancer Institute
Co-authored papers
14
Richard A Scolyer
Co-authored papers
10
Eberhard Korsching
Institutet of Bioinformatics, University Hospital of Munster, University of Munster
Co-authored papers
10
Thomas Decker
University of Vienna
Co-authored papers
10
Josephine C Dorsman
Cancer Center Amsterdam
Co-authored papers
9
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Co-authored papers
9
Quirine F Manson
Alrijne Hospital Leiderdorp
Co-authored papers
9
Jeroen A W M van der Laak
Radboud University Medical Center
Co-authored papers
8
Ruud H Brakenhoff
Vrije Universiteit Amsterdam
Co-authored papers
7
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers
6
Petra H M Peeters
Co-authored papers
6
Edwin Cuppen
Hartwig Medical Foundation
Co-authored papers
6
Carolien P Schr??der
University of Groningen, University Medical Center Groningen
Co-authored papers
6
Jos Jonkers
Oncode Institute, Netherlands Cancer Institute
Co-authored papers
5
Nasir Rajpoot
University of Warwick, University Hospitals Coventry, UK The Alan Turing Institute
Co-authored papers
5
Wilbert Zwart
Oncode Institute, The Netherlands Cancer Institute
Co-authored papers
5
John M S Bartlett
University of Edinburgh
Co-authored papers
5
Tesa M Severson
Oncode Institute, The Netherlands Cancer Institute
Co-authored papers
5
William E Grizzle
University of Alabama at Birmingham
Co-authored papers
5
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers
5
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers
4
David L Rimm
Yale University School of Medicine
Co-authored papers
4
Hans Clevers
Princess Maxima Center for Pediatric Oncology
Co-authored papers
4
Charles R Leemans
Location Vrije Universiteit Amsterdam
Co-authored papers
4
1 - 30